Based on our first report examining the role of the conditional oncogenic complex NTSR2-TrkB, expressed on B-CLL (Supplementary Fig. S1) in maintaining their survival, we speculated that NLC increase expression of this complex in pro-survival centers. The gene discussed is NTRK2; the disease is B-cell chronic lymphocytic leukemia.